Evidence map›Paper›PMID 42707577›Full record

ArticleActa crystallographica. Section E, Crystallographic communications2026

A second ortho-rhom-bic polymorph of 3-ferro-cenylacrylaldehyde.

Evgeniya R Shelukho, Vladimir P Zaytsev, Victor N Khrustalev, Tuncer Hökelek, Alebel N Belay, Khudayar I Hasanov, Narmina A Guliyeva

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Acta crystallographica. Section E, Crystallographic communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Evgeniya R ShelukhoRUDN University, 6 Miklukho-Maklaya St., Moscow 117198, Russian Federation.ORCID https://orcid.org/0000-0003-1310-6536
Vladimir P ZaytsevRUDN University, 6 Miklukho-Maklaya St., Moscow 117198, Russian Federation.
Victor N KhrustalevRUDN University, 6 Miklukho-Maklaya St., Moscow 117198, Russian Federation.ORCID https://orcid.org/0000-0001-8806-2975
Tuncer HökelekHacettepe University, Department of Physics, 06800 Beytepe-Ankara, Türkiye.ORCID https://orcid.org/0000-0002-8602-4382
Alebel N BelayDepartment of Chemistry, Bahir Dar University, PO Box 79, Bahir Dar, Ethiopia.ORCID https://orcid.org/0000-0003-4175-5656
Khudayar I HasanovScientific Research Centre (SRC), Azerbaijan Medical University, A. Kasumzade St. 14, AZ 1022, Baku, Azerbaijan.
Narmina A GuliyevaDepartment of Chemical Engineering, Baku Engineering University, Hasan Aliyev str. 120, AZ0101, Khirdalan, Absheron, Azerbaijan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The title compound (systematic name: 3-ferrocenylprop-2-en-1-one), [Fe(C

Indexed as

crystal structureferrocene derivativesweak inter­actions

Identifiers

PMID42707577
PMCPMC13548766

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.